Quantum Biopharma (QNTM) Long-Term Debt Repayments (2021)
Quantum Biopharma recorded quarterly Long-Term Debt Repayments of -$335.0 in Q3 2021, up 99.22% quarter-over-quarter from -$43164.0 in Q2 2021.
Quantum Biopharma's Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at -$335.0 for Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -335.00 |
| Sep 30, 2021 | -335.00 |
| Jun 30, 2021 | -43,164.00 |
| Jun 30, 2021 | -43,164.00 |
| Mar 31, 2021 | -28,260.00 |
| Mar 31, 2021 | -28,260.00 |